Cargando…

Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia

Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizamutdinov, Damir, Qi, Xiaoming, Berman, Marvin H, Dougal, Gordon, Dayawansa, Samantha, Wu, Erxi, Yi, S. Stephen, Stevens, Alan B, Huang, Jason H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219492/
https://www.ncbi.nlm.nih.gov/pubmed/34221541
http://dx.doi.org/10.14336/AD.2021.0229
_version_ 1783710939539832832
author Nizamutdinov, Damir
Qi, Xiaoming
Berman, Marvin H
Dougal, Gordon
Dayawansa, Samantha
Wu, Erxi
Yi, S. Stephen
Stevens, Alan B
Huang, Jason H
author_facet Nizamutdinov, Damir
Qi, Xiaoming
Berman, Marvin H
Dougal, Gordon
Dayawansa, Samantha
Wu, Erxi
Yi, S. Stephen
Stevens, Alan B
Huang, Jason H
author_sort Nizamutdinov, Damir
collection PubMed
description Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and potential therapeutic benefits of tNIR light stimulations in the treatment of dementia. Patients of mild to moderate dementia were randomized into active and sham treatment groups at 2:1 ratio. Active treatment consisted of low power tNIR light stimulations with an active photobiomodulation for 6 min twice daily during 8 consequent weeks. Sham treatment consisted of same treatment routine with a sham device. Neuropsychological battery was obtained before and after treatment. Analysis of variance (ANOVA) was used to analyze outcomes. Sixty subjects were enrolled. Fifty-seven subjects completed the study and had not reported health or adverse side effects during or after the treatment. Three subjects dropped out from trial for health issues unrelated to use of tNIR light treatment. Treatment with active device resulted in improvements of cognitive functions and changes were: an average increase of MMSE by 4.8 points; Logical Memory Tests I and II by ~3.0 points; Trail Making Tests A and B by ~24%; Boston Naming Test by ~9%; improvement of both Auditory Verbal Learning Tests in all subtest categories and overall time of performance. Many patients reported improved sleep after ~7 days of treatment. Caregivers noted that patients had less anxiety, improved mood, energy, and positive daily routine after ~14-21 days of treatment. The tNIR light treatments demonstrated safety and positive cognitive improvements in patients with dementia. Developed treatment protocol can be conveniently used at home. This study suggests that additional dementia treatment trials are warranted with a focus on mitigating caregivers’ burden with tNIR light treatment of dementia patients.
format Online
Article
Text
id pubmed-8219492
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-82194922021-07-03 Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia Nizamutdinov, Damir Qi, Xiaoming Berman, Marvin H Dougal, Gordon Dayawansa, Samantha Wu, Erxi Yi, S. Stephen Stevens, Alan B Huang, Jason H Aging Dis Short Communications Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and potential therapeutic benefits of tNIR light stimulations in the treatment of dementia. Patients of mild to moderate dementia were randomized into active and sham treatment groups at 2:1 ratio. Active treatment consisted of low power tNIR light stimulations with an active photobiomodulation for 6 min twice daily during 8 consequent weeks. Sham treatment consisted of same treatment routine with a sham device. Neuropsychological battery was obtained before and after treatment. Analysis of variance (ANOVA) was used to analyze outcomes. Sixty subjects were enrolled. Fifty-seven subjects completed the study and had not reported health or adverse side effects during or after the treatment. Three subjects dropped out from trial for health issues unrelated to use of tNIR light treatment. Treatment with active device resulted in improvements of cognitive functions and changes were: an average increase of MMSE by 4.8 points; Logical Memory Tests I and II by ~3.0 points; Trail Making Tests A and B by ~24%; Boston Naming Test by ~9%; improvement of both Auditory Verbal Learning Tests in all subtest categories and overall time of performance. Many patients reported improved sleep after ~7 days of treatment. Caregivers noted that patients had less anxiety, improved mood, energy, and positive daily routine after ~14-21 days of treatment. The tNIR light treatments demonstrated safety and positive cognitive improvements in patients with dementia. Developed treatment protocol can be conveniently used at home. This study suggests that additional dementia treatment trials are warranted with a focus on mitigating caregivers’ burden with tNIR light treatment of dementia patients. JKL International LLC 2021-07-01 /pmc/articles/PMC8219492/ /pubmed/34221541 http://dx.doi.org/10.14336/AD.2021.0229 Text en copyright: © 2021 Nizamutdinov et al. https://creativecommons.org/licenses/by/2.0/this is an open access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Short Communications
Nizamutdinov, Damir
Qi, Xiaoming
Berman, Marvin H
Dougal, Gordon
Dayawansa, Samantha
Wu, Erxi
Yi, S. Stephen
Stevens, Alan B
Huang, Jason H
Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title_full Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title_fullStr Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title_full_unstemmed Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title_short Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
title_sort transcranial near infrared light stimulations improve cognition in patients with dementia
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219492/
https://www.ncbi.nlm.nih.gov/pubmed/34221541
http://dx.doi.org/10.14336/AD.2021.0229
work_keys_str_mv AT nizamutdinovdamir transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT qixiaoming transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT bermanmarvinh transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT dougalgordon transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT dayawansasamantha transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT wuerxi transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT yisstephen transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT stevensalanb transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia
AT huangjasonh transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia